Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Spyre Therapeutics launches underwritten public offering of common stock

Spyre Therapeutics launches underwritten public offering of common stock

BitgetBitget2026/10/05 20:01

Spyre Therapeutics launched an underwritten public offering of common stock. Underwriters receive a 30-day option to buy up to 15% additional shares on the same terms. Jefferies, TD Cowen, Leerink Partners, Stifel serve as joint bookrunners; LifeSci Capital acts as passive bookrunner. Proceeds earmarked for immunology pipeline development, including SPY072 late-stage work in hidradenitis suppurativa. Deal terms remain subject to market conditions; pricing, size, timing not disclosed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051601PRIMZONEFULLFEED9839893) on October 05, 2026, and is solely responsible for the information contained therein.

  • Spyre Therapeutics launched an underwritten public offering of common stock.
  • Underwriters receive a 30-day option to buy up to 15% additional shares on the same terms.
  • Jefferies, TD Cowen, Leerink Partners, Stifel serve as joint bookrunners; LifeSci Capital acts as passive bookrunner.
  • Proceeds earmarked for immunology pipeline development, including SPY072 late-stage work in hidradenitis suppurativa.
  • Deal terms remain subject to market conditions; pricing, size, timing not disclosed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051601PRIMZONEFULLFEED9839893) on October 05, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Boeing (BA.US) Max 10 certification expected to be announced next week, adding new leverage for debt relief

The Boeing 737 Max 10 has completed key certification meetings and could be approved as early as next week. As Boeing's largest variant to rival Airbus, this model will help airlines replace aging 757s and is expected to become a cash cow for Boeing to reduce its debt.

智通财经•2026/10/17 02:06
Boeing (BA.US) Max 10 certification expected to be announced next week, adding new leverage for debt relief

Foreign holdings of US Treasuries rebounded in August, with UK holdings surpassing $1 trillion for the first time

In August, foreign holdings of U.S. Treasury bonds increased by over 83 billions USD, with Canada and Belgium leading the increase; meanwhile, holdings by Japan and China continued to decline to multi-year lows, and for the first time, the UK's holdings surpassed 1 trillion USD.

智通财经•2026/10/17 01:21
Foreign holdings of US Treasuries rebounded in August, with UK holdings surpassing $1 trillion for the first time

New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March

A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.

华尔街见闻•2026/10/16 22:46
New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March